This is the next generation of the HammerLock implant with Nitinol technology, which is designed to provide surgeons with an intramedullary implant that does not require freezing. It is intended as a solution for hammertoe fixation. The HammerLock 2 is designed to fit a wider range of anatomies, and it includes many points of stabilization within the toe to prevent rotation.
More articles on devices:
Alphatec Spine 3Q revenue up 2%: 10 key concepts
NuVasive’s 3Q revenue up 12.3%: 10 things to know
Zimmer Biomet names new leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
